GlassScriptPhysician profile
Sandra Tincher
NPI 1972546232
$586.12
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $75.77 · 2021: $87.72 · 2022: $64.96 · 2023: $75.37 · 2024: $92.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $171.29 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $57.36 | 2020-2023 | Soliris |
| Exelixis INC. | $53.37 | 2019-2024 | Cabometyx |
| Incyte Corporation | $48.46 | 2022-2024 | Jakafi |
| Takeda Pharmaceuticals U.S.A., INC. | $37.07 | 2019-2024 | Fruzaqla |
| Lilly USA, LLC | $33.58 | 2019-2023 | Retevmo, Jaypirca, Verzenio |
| Bayer Healthcare Pharmaceuticals INC. | $19.85 | 2022 | |
| Sumitomo Pharma America, INC. | $17.24 | 2024 | Orgovyx |
| Celgene Corporation | $17.11 | 2019 | |
| Beigene USA, INC. | $16.90 | 2024 | Brukinsa |
| Lexicon Pharmaceuticals, INC. | $16.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.01 | 2019 | |
| Eisai INC. | $15.97 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $15.96 | 2019 | |
| Tactile Systems Technology INC | $13.55 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $13.03 | 2022 | |
| Focal Therapeutics, INC. | $12.06 | 2020 | |
| Fortovia Therapeutics, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Tincher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.